These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 31610171)

  • 1. Cell of Origin and Immunologic Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma.
    Turner SD; Inghirami G; Miranda RN; Kadin ME
    Am J Pathol; 2020 Jan; 190(1):2-10. PubMed ID: 31610171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-13 is produced by tumor cells in breast implant-associated anaplastic large cell lymphoma: implications for pathogenesis.
    Kadin ME; Morgan J; Xu H; Epstein AL; Sieber D; Hubbard BA; Adams WP; Bacchi CE; Goes JCS; Clemens MW; Medeiros LJ; Miranda RN
    Hum Pathol; 2018 Aug; 78():54-62. PubMed ID: 29689246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular and Molecular Mechanisms of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
    DeCoster RC; Clemens MW; Di Napoli A; Lynch EB; Bonaroti AR; Rinker BD; Butterfield TA; Vasconez HC
    Plast Reconstr Surg; 2021 Jan; 147(1):30e-41e. PubMed ID: 33370049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What Cytokines Can Tell Us About the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
    Kadin ME
    Aesthet Surg J; 2019 Jan; 39(Suppl_1):S28-S35. PubMed ID: 30715174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast implant-associated ALK-negative anaplastic large cell lymphoma: a case report and discussion of possible pathogenesis.
    George EV; Pharm J; Houston C; Al-Quran S; Brian G; Dong H; Hai W; Reeves W; Yang LJ
    Int J Clin Exp Pathol; 2013; 6(8):1631-42. PubMed ID: 23923082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast implant-associated anaplastic large cell lymphoma: A comprehensive review.
    Marra A; Viale G; Pileri SA; Pravettoni G; Viale G; De Lorenzi F; Nolè F; Veronesi P; Curigliano G
    Cancer Treat Rev; 2020 Mar; 84():101963. PubMed ID: 31958739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers Provide Clues to Early Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
    Kadin ME; Deva A; Xu H; Morgan J; Khare P; MacLeod RA; Van Natta BW; Adams WP; Brody GS; Epstein AL
    Aesthet Surg J; 2016 Jul; 36(7):773-81. PubMed ID: 26979456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast Implant-Associated Anaplastic Large Cell Lymphoma.
    Rastogi P; Deva AK; Prince HM
    Curr Hematol Malig Rep; 2018 Dec; 13(6):516-524. PubMed ID: 30345474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytological features of breast implant-associated anaplastic large cell lymphoma in pleural effusion.
    D'Alessandris N; Lucatelli P; Tripodi D; Amabile MI; Ascoli V
    Diagn Cytopathol; 2019 Nov; 47(11):1213-1217. PubMed ID: 31348611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UK Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) on behalf of the Medicines and Healthcare products Regulatory Agency (MHRA) Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group (PRASEAG).
    Turton P; El-Sharkawi D; Lyburn I; Sharma B; Mahalingam P; Turner SD; MacNeill F; Johnson L; Hamilton S; Burton C; Mercer N
    J Plast Reconstr Aesthet Surg; 2021 Jan; 74(1):13-29. PubMed ID: 33483089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast implant associated anaplastic large cell lymphoma: The UK experience. Recommendations on its management and implications for informed consent.
    Johnson L; O'Donoghue JM; McLean N; Turton P; Khan AA; Turner SD; Lennard A; Collis N; Butterworth M; Gui G; Bristol J; Hurren J; Smith S; Grover K; Spyrou G; Krupa K; Azmy IA; Young IE; Staiano JJ; Khalil H; MacNeill FA
    Eur J Surg Oncol; 2017 Aug; 43(8):1393-1401. PubMed ID: 28596034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zwitterionic polymer on silicone implants inhibits the bacteria-driven pathogenic mechanism and progress of breast implant-associated anaplastic large cell lymphoma.
    Kim J; Kang S; Choi MH; Park S; Nam SH; Park JU; Lee Y
    Acta Biomater; 2023 Nov; 171():378-391. PubMed ID: 37683967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
    Oishi N; Miranda RN; Feldman AL
    Aesthet Surg J; 2019 Jan; 39(Suppl_1):S14-S20. PubMed ID: 30715169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD30 Regulation of IL-13-STAT6 Pathway in Breast Implant-Associated Anaplastic Large Cell Lymphoma.
    Kadin ME; Morgan J; Wei W; Song Z; Yang Y
    Aesthet Surg J; 2023 Feb; 43(2):137-146. PubMed ID: 35999655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of a CD30 Enzyme-Linked Immunosorbant Assay for the Rapid Detection of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
    Hanson SE; Hassid VJ; Branch-Brooks C; Liu J; Kadin ME; Miranda R; Butler CE; Clemens MW
    Aesthet Surg J; 2020 Jan; 40(2):149-153. PubMed ID: 30789639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast Reconstruction Following Breast Implant-Associated Anaplastic Large Cell Lymphoma.
    Lamaris GA; Butler CE; Deva AK; Miranda RN; Hunt KK; Connell T; Lipa JE; Clemens MW
    Plast Reconstr Surg; 2019 Mar; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):51S-58S. PubMed ID: 30817556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does Breast Implant-Associated ALCL Begin as a Lymphoproliferative Disorder?
    Kadin ME; Adams WP; Inghirami G; Di Napoli A
    Plast Reconstr Surg; 2020 Jan; 145(1):30e-38e. PubMed ID: 31577659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL): an overview of presentation and pathogenesis and guidelines for pathological diagnosis and management.
    Jones JL; Hanby AM; Wells C; Calaminici M; Johnson L; Turton P; Deb R; Provenzano E; Shaaban A; Ellis IO; Pinder SE;
    Histopathology; 2019 Dec; 75(6):787-796. PubMed ID: 31166611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes.
    Laurent C; Delas A; Gaulard P; Haioun C; Moreau A; Xerri L; Traverse-Glehen A; Rousset T; Quintin-Roue I; Petrella T; Emile JF; Amara N; Rochaix P; Chenard-Neu MP; Tasei AM; Menet E; Chomarat H; Costes V; Andrac-Meyer L; Michiels JF; Chassagne-Clement C; de Leval L; Brousset P; Delsol G; Lamant L
    Ann Oncol; 2016 Feb; 27(2):306-14. PubMed ID: 26598546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous Regression and Resolution of Breast Implant-Associated Anaplastic Large Cell Lymphoma: Implications for Research, Diagnosis and Clinical Management.
    Fleming D; Stone J; Tansley P
    Aesthetic Plast Surg; 2018 Jun; 42(3):672-678. PubMed ID: 29445921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.